Prevalence and risk factors for genital high-risk human papillomavirus infection among women attending the out-patient clinics of a university teaching hospital in Lagos, Nigeria
- PMID: 29629013
- PMCID: PMC5882206
- DOI: 10.11604/pamj.2017.28.227.13979
Prevalence and risk factors for genital high-risk human papillomavirus infection among women attending the out-patient clinics of a university teaching hospital in Lagos, Nigeria
Abstract
Introduction: Cervical cancer is the second most common cancer among women in the developing countries and the seventh commonest cancer in the developed countries. Human papillomavirus (HPV) is now known to be the main factor in the aetiology of cervical cancer with over 99.7% of cases being associated with previous high risk HPV (hrHPV) infection. This study was aimed to determine the prevalence and risk factors for genital hrHPV infection among women attending the out-patient clinics of the Lagos University Teaching Hospital.
Methods: This was a cross-sectional study involving a total of 200 women. Questionnaires were administered to collect data such as sociodemographic, reproductive and sexual histories. Endocervical swab samples were then taken from each participant. Samples were analyzed by polymerase chain reaction (PCR) using consensus primers targeted against the hrHPV viruses.
Results: The prevalence of hrHPV in the study was 36.5%. The most predominant HPV subtypes were 31 (25.0%), 35 (8.0%) and 16 (3.5%) with the largest proportion (76.1%) of the tested samples being positive for only a single hrHPV subtype. The study showed statistically significant associations between early age at coitarche (P = 0.032) and increasing number of lifetime sexual partners (P = 0.001) with genital hrHPV infection.
Conclusion: The prevalence of hrHPV was high in Lagos with the majority of test positive samples having only a single HPV genotype. We demonstrated early age of sexual debut and increasing number of lifetime sexual partners as the most important factors associated with genital hrHPV infection.
Keywords: Genital; LUTH; PCR; genotypes; hrHPV; vaccination.
Figures
References
-
- Walbbmers JM, Jacob MV, Manos MM, Bosch FX, Kummer JA, Shah KV, et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol. 1999;189(1):12–19. - PubMed
-
- Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 200. CA Cancer J Clin. 2005;55(2):74–108. - PubMed
-
- WHO: International Agency for Research on Cancer . Cervical Cancer: Estimated Incidence, Mortality and Prevalence Worldwide in 2012. The GLOBOCAN 2012 database. International Agency for Research on Cancer; Accessed February 15, 2014.
-
- Sankaranarayanan R, Ferlay J. Worldwide burden of gynaecological cancer: the size of the problem. Best Pract Res Clin Obstet Gynaecol. 2006;20(2):207–22. - PubMed
-
- Forman D, de Martel C, Lacey C, et al. Global burden of human papillomavirus and related diseases. Vaccines. 2012;30(Suppl 5):12–23. - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources